In the US, around US$20 billion worth of funds are invested in biotech ETFs, while mutual funds have poured another US$40 billion of investment into the sector. Photo: Andrew Brookes/Corbis In the US, around US$20 billion worth of funds are invested in biotech ETFs, while mutual funds have poured another US$40 billion of investment into the sector. Photo: Andrew Brookes/Corbis
In the US, around US$20 billion worth of funds are invested in biotech ETFs, while mutual funds have poured another US$40 billion of investment into the sector. Photo: Andrew Brookes/Corbis
Pharmaceuticals
Tech

The best ways of climbing aboard the biotech investment bandwagon

Exchange traded or mutual funds allow those with no or limited knowledge of the biotech industry’s potential exposures to reduce risk

Topic |   Pharmaceuticals
Eric Ng
Eric Ng

Updated: 3:15pm, 15 Apr, 2018

Why you can trust SCMP
In the US, around US$20 billion worth of funds are invested in biotech ETFs, while mutual funds have poured another US$40 billion of investment into the sector. Photo: Andrew Brookes/Corbis In the US, around US$20 billion worth of funds are invested in biotech ETFs, while mutual funds have poured another US$40 billion of investment into the sector. Photo: Andrew Brookes/Corbis
In the US, around US$20 billion worth of funds are invested in biotech ETFs, while mutual funds have poured another US$40 billion of investment into the sector. Photo: Andrew Brookes/Corbis
READ FULL ARTICLE